Chat with us, powered by LiveChat

December 2017 Webinar Announcement

[dt_fancy_title title=”What If you could identify systemic toxicity in humans prior to entering clinical trials?” title_size=”big” separator_style=”disabled”][dt_fancy_title title=”Register For a Free Webinar on Human Relevant Multiple Organ Testing With Simulated Blood Flow” title_size=”h2″ separator_style=”disabled”]

December 6th at 1:00 PM EST


Learn about an innovative new platform that enables investigators to evaluate drug or chemical pharmacokinetics/pharmacodynamics and toxicity in an in vitro multiple organ model. 

Register For A Free Webinar with Toxicologist James McKim, Ph.D., DABT.

Click the button below to register for the December 6th, Webinar at 1:00 PM.

Limited to 100 seats

[dt_fancy_separator separator_style=”dashed”]
[dt_fancy_title title=”Understand Drug-Organ Interaction & Predict Systemic Toxicity In Humans” title_size=”big” separator_style=”disabled”][dt_fancy_title title=”What Dr. James McKim will Cover in the December 6th Webinar” title_size=”h1″ separator_style=”disabled”]

In This Webinar You Will Learn

An overview of current in vitro test systems where we are and where we are going.

The advantages and disadvantages of using current systems

The importance of linking multiple organs with a simulated blood flow for improved human biological relevance

Only 100 Seats Available!

Because of our current license with our webinar partner we only have 100 seats available for the December 6th Webinar.
[dt_fancy_separator separator_style=”dashed”]

 

 

About Dr. James McKim Ph.D., DABT,

Dr. McKim graduated from the doctoral program in biochemical and molecular toxicology at Oregon State University and has been a Diplomat of the American Board of Toxicology since 1995. Dr. McKim has served in leading roles as Head of the Biochemical Molecular Toxicology Group at DOW Corning and Research Fellow/head of the in vitro toxicology screening group at Pharmacia (later Pfizer). Following his time at Dow and Pharmacia, Dr. McKim founded two contract research organizations, CeeTox, Inc. and  IONTOX, LLC. Along with his current role as CEO/CSO of IONTOX, LLC, Dr. McKim serves as the Editor and Chief of Applied In Vitro Toxicology, a new international journal devoted to discussing the application of in vitro methods. Over his 25+ year career, Dr. McKim has published numerous scientific manuscripts, book chapters, and reviews distributed worldwide.

ib3 image
HuDMOP
Human Dynamic Multiple Organ Plate

Click the button below to reserve your spot

Click the button to sign up For the December 6th Webinar with Dr. James Mckim Ph.D., DABT, at 1:00PM